AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voxyta Met 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Aagam Life Sciences Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Voxyta Met 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney disease and vision loss, and may lessen heart attack or stroke risk. Diabex Duo may be used alone or with other diabetes treatments, and is most effective when combined with a balanced diet and regular physical activity. Dosage is personalized based on your health, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing, at the same time, maximizes benefits; discontinue only as advised by your physician. Maintaining your prescribed diet and exercise plan is crucial for diabetes control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and sore throat. Low blood sugar (hypoglycemia) is possible if used with insulin or sulfonylureas—learn to identify and manage this. This medication isn't for everyone. Inform your doctor about prior kidney, liver, or heart problems, pancreatic issues, or heavy alcohol use before starting. Pregnant or breastfeeding individuals should consult their physician. Other medications may interact with Diabex Duo, so disclose all medications to ensure safety. Alcohol should be limited due to its blood sugar-lowering effect. Your doctor will monitor kidney function and blood sugar throughout treatment.

Primary Ingredients of Voxyta Met 50mg/500mg Tablet

No information provided. Please provide the text you wish to be rephrased.

Uses of Voxyta Met 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Voxyta Met 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Voxyta Met 50mg/500mg tablets with a meal.

Common Side effects of Voxyta Met 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Voxyta Met 50mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Voxyta Met 50mg/500mg tablet whole; avoid chewing, crushing, or fracturing. Consume with food.

How Voxyta Met 50mg/500mg Tablet works:

Voxyta Met 50mg/500mg tablets combine sitagliptin and metformin to improve blood glucose management. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and boosting insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voxyta Met 50mg/500mg Tablet with alcohol is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Voxyta Met 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Voxyta Met 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Voxyta Met 50mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. Voxyta Met 50mg/500mg tablets are contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver impairment should likely refrain from using Voxyta Met 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Voxyta Met 50mg/500mg Tablet :

Should you forget a Voxyta Met 50mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voxyta Met 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Voxyta Met 50mg/500mg Tablet

Voxyta Met 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Voxyta Met 50mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Voxyta Met 50mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Voxyta Met 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Voxyta Met 50mg/500mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA—Metformin-associated lactic acidosis), is a potential side effect of Voxyta Met 50mg/500mg tablets. This occurs due to elevated blood lactic acid levels. Because it's rare, metformin is avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Voxyta Met 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18 years old.
Voxyta Met 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Voxyta Met 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Voxyta Met 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid, is a potential side effect of Voxyta Met 50mg/500mg tablets (also known as Metformin-associated lactic acidosis or MALA). While rare, this risk is heightened in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin immediately and seek urgent medical attention.
Prolonged use of Voxyta Met 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Voxyta Met 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Voxyta Met 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Voxyta Met 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Voxyta Met 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA – Metformin-associated lactic acidosis), is a potential side effect of Voxyta Met 50mg/500mg Tablets. This occurs due to excessive lactic acid buildup in the blood. Because it's rare, metformin use is avoided in patients with kidney disease, the elderly, and heavy alcohol consumers. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Prolonged use of Voxyta Met 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Voxyta Met 50mg/500mg Tab...
243